LIGAND PHARMACEUTICALS INC Quarterly Operating Lease, Right-of-Use Asset in USD from Q4 2018 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Ligand Pharmaceuticals Inc quarterly Operating Lease, Right-of-Use Asset history and growth rate from Q4 2018 to Q2 2024.
  • Ligand Pharmaceuticals Inc Operating Lease, Right-of-Use Asset for the quarter ending June 30, 2024 was $7.4M, a 35% decline year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 $7.4M -$3.99M -35% Jun 30, 2024 10-Q 2024-08-07
Q1 2024 $6.03M -$5.64M -48.3% Mar 31, 2024 10-Q 2024-05-08
Q4 2023 $6.06M -$4.85M -44.5% Dec 31, 2023 10-Q 2024-08-07
Q3 2023 $6.24M -$25.9M -80.6% Sep 30, 2023 10-Q 2023-11-09
Q2 2023 $11.4M -$13.3M -53.9% Jun 30, 2023 10-Q 2023-08-09
Q1 2023 $11.7M -$4.12M -26.1% Mar 31, 2023 10-Q 2023-05-08
Q4 2022 $10.9M +$7.7M +240% Dec 31, 2022 10-K 2024-02-29
Q3 2022 $32.1M +$19.2M +148% Sep 30, 2022 10-Q 2022-11-08
Q2 2022 $24.7M +$18.2M +280% Jun 30, 2022 10-Q 2022-08-09
Q1 2022 $15.8M +$8.17M +107% Mar 31, 2022 10-Q 2022-05-09
Q4 2021 $3.21M -$3.68M -53.4% Dec 31, 2021 10-K 2023-02-28
Q3 2021 $13M +$8.68M +203% Sep 30, 2021 10-Q 2021-11-09
Q2 2021 $6.5M -$3.19M -32.9% Jun 30, 2021 10-Q 2021-08-03
Q1 2021 $7.61M -$2.02M -21% Mar 31, 2021 10-Q 2021-05-06
Q4 2020 $6.89M -$3.46M -33.4% Dec 31, 2020 10-K 2022-02-28
Q3 2020 $4.27M -$6.01M -58.5% Sep 30, 2020 10-Q 2020-11-06
Q2 2020 $9.69M -$1.28M -11.6% Jun 30, 2020 10-Q 2020-08-07
Q1 2020 $9.63M +$4.75M +97.3% Mar 31, 2020 10-Q 2020-05-08
Q4 2019 $10.4M +$10.4M Dec 31, 2019 10-K 2021-02-24
Q3 2019 $10.3M Sep 30, 2019 10-Q 2019-11-08
Q2 2019 $11M Jun 30, 2019 10-Q 2019-08-08
Q1 2019 $4.88M Mar 31, 2019 10-Q 2019-05-09
Q4 2018 $0 Dec 31, 2018 10-K 2020-02-27
* An asterisk sign (*) next to the value indicates that the value is likely invalid.